Natur
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Investors Count
2Natur Funding, Natur Valuation & Natur Revenue
2 Fundings
Natur's latest funding round was a Reverse Merger for on November 19, 2018.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
11/19/2018 | Reverse Merger | 1 | ||||
8/28/2017 | Merger |
Date | 11/19/2018 | 8/28/2017 |
|---|---|---|
Round | Reverse Merger | Merger |
Amount | ||
Investors | ||
Valuation | ||
Revenue | ||
Sources | 1 |
Financials
Income Statement
Income Statement | 12/31/2021 | 12/31/2020 | 12/31/2019 |
|---|---|---|---|
Total Sales (or Revenue) | |||
Cost of Goods Sold (COGS) including Depreciation and Ammortization | |||
Gross Income | |||
SG&A Excluding Other | |||
Other Operating Expense | |||
EBIT (Operating Income) | |||
Non-Operating Income (Expense) | |||
Interest Expense | |||
Usual Expense | |||
Pretax Income | |||
Income Taxes | |||
Equity in Earnings of Affiliates Income | |||
Other After Tax Adjustments | |||
Consolidated Net Income | |||
Minority Interest Expense | |||
Net Income From Continuing Operations | |||
Preferred Dividends | |||
Net Income Available to Common | |||
EPS (Recurring) | |||
EPS - Basic - Before Extraordinaries | |||
EPS (Diluted) | |||
EBITDA | |||
Stock Option Compensation Expense | |||
Operating Lease Expense | |||
Foreign Currency Adjustment (Net) |
Income Statement | Total Sales (or Revenue) | Cost of Goods Sold (COGS) including Depreciation and Ammortization | Gross Income | SG&A Excluding Other | Other Operating Expense | EBIT (Operating Income) | Non-Operating Income (Expense) | Interest Expense | Usual Expense | Pretax Income | Income Taxes | Equity in Earnings of Affiliates Income | Other After Tax Adjustments | Consolidated Net Income | Minority Interest Expense | Net Income From Continuing Operations | Preferred Dividends | Net Income Available to Common | EPS (Recurring) | EPS - Basic - Before Extraordinaries | EPS (Diluted) | EBITDA | Stock Option Compensation Expense | Operating Lease Expense | Foreign Currency Adjustment (Net) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/31/2021 | |||||||||||||||||||||||||
12/31/2020 | |||||||||||||||||||||||||
12/31/2019 |
All numbers in millions (except EPS)Market Data by Xignite
Financials
Balance Sheet
Balance Sheet | 12/31/2021 | 12/31/2020 | 12/31/2019 |
|---|---|---|---|
Cash & Short Term Investments | |||
Inventories | |||
Other Current Assets | |||
Total Current Assets | |||
Net Property, Plant & Equipment | |||
Total Investments and Advances | |||
Long-Term Note Receivable | |||
Intangible Assets | |||
Deferred Tax Assets | |||
Other Assets | |||
Total Assets | |||
Short Term Debt (including Current Portion of Long Term Debt) | |||
Accounts Payable | |||
Income Tax Payable | |||
Other Current Liabilities | |||
Total Current Liabilities | |||
Long Term Debt | |||
Provision for Risks Charges | |||
Deferred Tax Liabilities | |||
Other Liabilities | |||
Total Liabilities | |||
Non-Equity Reserves | |||
Preferred Stock - Carrying Value | |||
Common Equity | |||
Total Shareholders Equity | |||
Accumulated Minority Interest | |||
Total Equity | |||
Total Liabilites & Stockholders Equity | |||
Book Value Per Share | |||
Tangible Book Value Per Share |
Balance Sheet | Cash & Short Term Investments | Inventories | Other Current Assets | Total Current Assets | Net Property, Plant & Equipment | Total Investments and Advances | Long-Term Note Receivable | Intangible Assets | Deferred Tax Assets | Other Assets | Total Assets | Short Term Debt (including Current Portion of Long Term Debt) | Accounts Payable | Income Tax Payable | Other Current Liabilities | Total Current Liabilities | Long Term Debt | Provision for Risks Charges | Deferred Tax Liabilities | Other Liabilities | Total Liabilities | Non-Equity Reserves | Preferred Stock - Carrying Value | Common Equity | Total Shareholders Equity | Accumulated Minority Interest | Total Equity | Total Liabilites & Stockholders Equity | Book Value Per Share | Tangible Book Value Per Share |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/31/2021 | ||||||||||||||||||||||||||||||
12/31/2020 | ||||||||||||||||||||||||||||||
12/31/2019 |
All numbers in millions (except EPS)Market Data by Xignite
Financials
Cash Flow
Cash Flow | 12/31/2021 | 12/31/2020 | 12/31/2019 |
|---|---|---|---|
Net Income (Starting Line) | |||
Depreciation | |||
Deferred Taxes & Investment Tax Credit | |||
Other Funds (Non Cash) | |||
Funds from Operations | |||
Extraordinary Item | |||
Changes in Working Capital | |||
Net Operating Cash Flow | |||
Capital Expenditures | |||
Net Assets From Acquisitions | |||
Sale of Fixed Assets and Businesses | |||
Purchase or Sale of Investments | |||
Other Uses | |||
Other Sources | |||
Net Investing Cash Flow | |||
Cash Dividends Paid | |||
Change in Capital Stock | |||
Issuance or Reduction of Debt, Net | |||
Net Financing Active Other Cash Flow | |||
Net Financing Cash Flow | |||
Exchange Rate Effect | |||
Miscellaneous Funds | |||
Net Change in Cash | |||
Free Cash Flow |
Cash Flow | Net Income (Starting Line) | Depreciation | Deferred Taxes & Investment Tax Credit | Other Funds (Non Cash) | Funds from Operations | Extraordinary Item | Changes in Working Capital | Net Operating Cash Flow | Capital Expenditures | Net Assets From Acquisitions | Sale of Fixed Assets and Businesses | Purchase or Sale of Investments | Other Uses | Other Sources | Net Investing Cash Flow | Cash Dividends Paid | Change in Capital Stock | Issuance or Reduction of Debt, Net | Net Financing Active Other Cash Flow | Net Financing Cash Flow | Exchange Rate Effect | Miscellaneous Funds | Net Change in Cash | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/31/2021 | ||||||||||||||||||||||||
12/31/2020 | ||||||||||||||||||||||||
12/31/2019 |
All numbers in millions (except EPS)Market Data by Xignite
Natur Investors
2 Investors
Natur has 2 investors. Future Healthcare of America invested in Natur's Reverse Merger funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
11/19/2018 | 11/19/2018 | 1 Reverse Merger | Corporation | Florida | ||
Corporation |
First funding | 11/19/2018 | |
|---|---|---|
Last Funding | 11/19/2018 | |
Investor | ||
Rounds | 1 Reverse Merger | |
Board Seats | ||
Type | Corporation | Corporation |
Location | Florida |
Natur Acquisitions
1 Acquisition
Natur acquired 1 company. Their latest acquisition was Temple Turmeric on July 31, 2019.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
7/31/2019 | Series A | $3.24M | Corporate Majority - II | 1 |
Date | 7/31/2019 |
|---|---|
Investment Stage | Series A |
Companies | |
Valuation | |
Total Funding | $3.24M |
Note | Corporate Majority - II |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.